Spectrum Pharmaceuticals Appoints New President and COO - - BioPharm International


Spectrum Pharmaceuticals Appoints New President and COO

Spectrum Pharmaceuticals, a biotechnology company with a primary focus in hematology and oncology, has appointed Joseph Turgeon, previously senior vice president and COO, as president and COO, replacing Ken Keller. Thomas Riga, previously vice president, corporate accounts, will become the senior vice president, COO.

Turgeon joined Spectrum in October 2012 and has over 30 years of pharmaceutical sales experience. Prior to joining the Spectrum, hespent 22 years at Amgen as VP of sales. Riga has over 15 years of pharmaceutical sales and management experience and has worked at Amgen, EliLilly, and Dendreon.

Source: Spectrum Pharmaceuticals

blog comments powered by Disqus



NIH Launches Human Safety Study of Ebola Vaccine Candidate
August 29, 2014
Suppliers Seek to Boost Single-Use Technology
August 21, 2014
Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen
August 20, 2014
FDA Warns about Fraudulent Ebola Treatments
August 15, 2014
USP Awards Analytical Research
August 15, 2014
Author Guidelines

Click here